Alto Neuroscience, Inc.

Direct answer

Alto Neuroscience, Inc. is publicly traded on NYSE under the ticker ANRO.

Alto Neuroscience, Inc. operates as a biopharmaceutical entity in the clinical stage, specializing in the creation of novel psychiatric medications. Its development pipeline includes ALTO-100, an investigational therapy targeting individuals affected by major depressive disorder (MDD) and post-traumatic stress disorder. Also in its portfolio is ALTO-300, a small molecule designed to function as both a melatonergic...

Can you invest in Alto Neuroscience, Inc.?

Yes. Alto Neuroscience, Inc. is publicly traded on NYSE under the ticker ANRO.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Alto Neuroscience, Inc.

Detailed equity research is provided by MarketSnap.